{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T22:48:05Z","timestamp":1753051685027},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor, and Welfare of Japan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.cyto.2011.09.003","type":"journal-article","created":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T06:40:51Z","timestamp":1317624051000},"page":"676-679","source":"Crossref","is-referenced-by-count":5,"title":["Interferon production by cells infected with subacute sclerosing panencephalitis (SSPE) virus or measles virus"],"prefix":"10.1016","volume":"56","author":[{"given":"Shunji","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Matsushige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ichiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2011.09.003_b0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.micinf.2009.01.009","article-title":"Single-point mutations of the M protein of a measles virus variant obtained from a patient with subacute sclerosing panencephalitis critically affect solubility and subcellular localization of the M protein and cell-free virus production","volume":"11","author":"Jiang","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.cyto.2011.09.003_b0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1348-0421.2006.tb03822.x","article-title":"Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE","volume":"50","author":"Hotta","year":"2006","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.cyto.2011.09.003_b0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0166-3542(97)00055-7","article-title":"The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo","volume":"37","author":"Takahashi","year":"1998","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cyto.2011.09.003_b0020","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.clinthera.2004.11.002","article-title":"Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis","volume":"26","author":"Anlar","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.cyto.2011.09.003_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.braindev.2004.07.003","article-title":"Long-term follow-up of a patient with subacute sclerosing panencephalitis successfully treated with intrathecal interferon alpha","volume":"27","author":"Miyazaki","year":"2005","journal-title":"Brain Dev"},{"key":"10.1016\/j.cyto.2011.09.003_b0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1607-551X(09)70485-1","article-title":"Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report","volume":"19","author":"Han","year":"2003","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.cyto.2011.09.003_b0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1212\/01.WNL.0000130516.54312.A1","article-title":"Improvement of SSPE by intrathecal infusion of alpha-IFN","volume":"63","author":"Kurata","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2011.09.003_b0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1212\/WNL.48.2.526","article-title":"Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon","volume":"48","author":"Anlar","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2011.09.003_b0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0887-8994(03)00040-7","article-title":"Onset of generalized seizures after intrathecal interferon therapy of SSPE","volume":"29","author":"Caksen","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.cyto.2011.09.003_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cyto.2005.11.009","article-title":"Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea","volume":"33","author":"Ichiyama","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2011.09.003_b0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.braindev.2009.04.018","article-title":"Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis","volume":"32","author":"Aydin","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.cyto.2011.09.003_b0060","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1128\/JCM.40.5.1733-1738.2002","article-title":"Comparative analysis of titers of antibodies against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups","volume":"40","author":"Itoh","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cyto.2011.09.003_b0065","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/JCM.35.10.2651-2653.1997","article-title":"Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan","volume":"35","author":"Katayama","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cyto.2011.09.003_b0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/JVI.64.2.700-705.1990","article-title":"Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus","volume":"64","author":"Kobune","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2011.09.003_b0075","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1099\/0022-1317-75-12-3511","article-title":"Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures","volume":"75","author":"Shibahara","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cyto.2011.09.003_b0080","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.4049\/jimmunol.179.9.6123","article-title":"Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus","volume":"179","author":"Shingai","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.09.003_b0085","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/NEN.0b013e3181d5d053","article-title":"Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant","volume":"69","author":"Jagessar","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.cyto.2011.09.003_b0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.virol.2009.05.005","article-title":"Antiviral activity and host gene induction by tamarin and marmoset interferon-alpha and interferon-gamma in the GBV-B primary hepatocyte culture model","volume":"390","author":"Chavez","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2011.09.003_b0095","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2567.2007.02727.x","article-title":"Isolation and characterization of dendritic cells from common marmosets for preclinical cell therapy studies","volume":"123","author":"Ohta","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2011.09.003_b0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virol.2010.07.011","article-title":"Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates","volume":"406","author":"Schaap-Nutt","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2011.09.003_b0105","doi-asserted-by":"crossref","first-page":"e11159","DOI":"10.1371\/journal.pone.0011159","article-title":"New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells","volume":"5","author":"Prescott","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2011.09.003_b0110","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/clinchem\/45.9.1693","article-title":"Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology","volume":"45","author":"Chen","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.cyto.2011.09.003_b0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-1759(01)00407-0","article-title":"Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics","volume":"254","author":"Cook","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cyto.2011.09.003_b0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1084\/jem.189.4.663","article-title":"Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo","volume":"189","author":"Leib","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.09.003_b0125","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-\u03b1\/\u03b2 and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.cyto.2011.09.003_b0130","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-\u03bb), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2011.09.003_b0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2011.09.003_b0140","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/eji.200324610","article-title":"Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells","volume":"34","author":"Coccia","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2011.09.003_b0145","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family","volume":"30","author":"Donnelly","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cyto.2011.09.003_b0150","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4049\/jimmunol.182.3.1296","article-title":"Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection","volume":"182","author":"Wang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.09.003_b0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1189\/jlb.1208761","article-title":"Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses","volume":"86","author":"Li","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cyto.2011.09.003_b0160","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1099\/vir.0.80904-0","article-title":"Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model","volume":"86","author":"Bartlett","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cyto.2011.09.003_b0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-\u03bb mediates antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2011.09.003_b0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2011.09.003_b0175","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","article-title":"Interferon-lambda serum levels in hepatitis C","volume":"54","author":"Langhans","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2011.09.003_b0180","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1128\/JVI.00078-07","article-title":"Cell\u2013cell fusion induced by measles virus amplifies the type I interferon response","volume":"81","author":"Herschke","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2011.09.003_b0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cyto.2005.08.004","article-title":"Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis","volume":"32","author":"Saruhan-Direskeneli","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2011.09.003_b0190","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.42.3.488","article-title":"Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis","volume":"42","author":"Yalaz","year":"1992","journal-title":"Neurology"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346661100723X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346661100723X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T11:26:02Z","timestamp":1593084362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346661100723X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S104346661100723X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2011.09.003","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}